Clinical Trials on 按部位分类的肿瘤 in Hong Kong
总计2020个结果
-
The University of Hong Kong未知NSCLC IV期 | EGFR激活突变 | 非小细胞肺癌 IIIB 期香港
-
Vivian Wing Yan LeeHoffmann-La Roche; Queen Elizabeth Hospital, Hong Kong; Princess Margaret Hospital, Hong Kong终止
-
Vivian Wing Yan LeeHoffmann-La Roche; Pamela Youde Nethersole Eastern Hospital; Princess Margaret Hospital, Hong...完全的
-
Hospital Authority, Hong KongEli Lilly and Company未知
-
Organisation for Oncology and Translational Research未知
-
Chinese University of Hong KongQueen Elizabeth Hospital, Hong Kong; United Christian Hospital未知
-
The University of Hong KongNovartis招聘中原发性骨髓纤维化 | 真性红细胞增多症 | 原发性血小板增多症 | 骨髓增殖性肿瘤 | 真性红细胞增多症后骨髓纤维化 | 原发性血小板增多症后骨髓纤维化 | 原发性骨髓纤维化,纤维化前期 | 原发性骨髓纤维化,纤维化阶段香港
-
Yung NAQueen Mary Hospital, Hong Kong; Pamela Youde Nethersole Eastern Hospital招聘中
-
Chinese University of Hong Kong完全的
-
Hospital Authority, Hong KongThe Hong Kong Nasopharyngeal Cancer Study Group终止
-
Hospital Authority, Hong KongHong Kong Nasopharyngeal Cancer Study Group Limited未知
-
Chinese University of Hong Kong完全的
-
Hong Kong Nasopharyngeal Cancer Study Group LimitedSanofi; The University of Hong Kong; Merck Sharp & Dohme LLC; Roche Pharma AG完全的
-
The University of Hong KongQueen Mary Hospital, Hong Kong完全的
-
Hospital Authority, Hong KongHong Kong Nasopharyngeal Cancer Study Group Limited未知
-
The University of Hong KongChinese University of Hong Kong完全的
-
The University of Hong Kong招聘中
-
National University Hospital, SingaporeAstraZeneca; Singapore Clinical Research Institute未知